Relating to human services; limiting the use of prior authorization under
medical assistance (MA) programs for certain prescription drugs prescribed for
the treatment of cancer, human immunodeficiency virus infection, acquired
immunodeficiency syndrome or transplantation having no generically equivalent
drug available under certain conditions
(je)